BLRX
Price
$4.49
Change
+$0.09 (+2.05%)
Updated
Jun 27, 04:55 PM (EDT)
Capitalization
16.42M
KMSTF
Price
$5.06
Change
-$0.04 (-0.78%)
Updated
Mar 18 closing price
Capitalization
30.72M
Interact to see
Advertisement

BLRX vs KMSTF

Header iconBLRX vs KMSTF Comparison
Open Charts BLRX vs KMSTFBanner chart's image
BioLineRx
Price$4.49
Change+$0.09 (+2.05%)
Volume$125
Capitalization16.42M
KADIMASTEM
Price$5.06
Change-$0.04 (-0.78%)
Volume$150
Capitalization30.72M
BLRX vs KMSTF Comparison Chart in %
Loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLRX vs. KMSTF commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRX is a Buy and KMSTF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (BLRX: $4.40 vs. KMSTF: $5.06)
Brand notoriety: BLRX and KMSTF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLRX: 6% vs. KMSTF: 100%
Market capitalization -- BLRX: $16.42M vs. KMSTF: $30.72M
BLRX [@Biotechnology] is valued at $16.42M. KMSTF’s [@Biotechnology] market capitalization is $30.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLRX’s FA Score shows that 1 FA rating(s) are green whileKMSTF’s FA Score has 0 green FA rating(s).

  • BLRX’s FA Score: 1 green, 4 red.
  • KMSTF’s FA Score: 0 green, 5 red.
According to our system of comparison, BLRX is a better buy in the long-term than KMSTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLRX’s TA Score shows that 3 TA indicator(s) are bullish.

  • BLRX’s TA Score: 3 bullish, 5 bearish.

Price Growth

BLRX (@Biotechnology) experienced а -3.72% price change this week, while KMSTF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

BLRX is expected to report earnings on May 27, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMSTF($30.7M) has a higher market cap than BLRX($16.4M). KMSTF YTD gains are higher at: -20.987 vs. BLRX (-48.598). BLRX has higher annual earnings (EBITDA): 8.5M vs. KMSTF (-9.53M). BLRX has higher revenues than KMSTF: BLRX (22.3M) vs KMSTF (0).
BLRXKMSTFBLRX / KMSTF
Capitalization16.4M30.7M53%
EBITDA8.5M-9.53M-89%
Gain YTD-48.598-20.987232%
P/E RatioN/AN/A-
Revenue22.3M0-
Total Cash26.4MN/A-
Total Debt13.7MN/A-
FUNDAMENTALS RATINGS
BLRX: Fundamental Ratings
BLRX
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KTB65.111.63
+2.57%
Kontoor Brands
ES63.250.79
+1.26%
Eversource Energy
JYNT11.610.11
+0.96%
Joint Corp (The)
SLRC16.080.12
+0.75%
SLR Investment Corp
HOTH1.17-0.02
-1.68%
Hoth Therapeutics

BLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLRX has been loosely correlated with PYXS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BLRX jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLRX
1D Price
Change %
BLRX100%
-1.90%
PYXS - BLRX
42%
Loosely correlated
-7.81%
KURA - BLRX
35%
Loosely correlated
-1.21%
DWTX - BLRX
33%
Loosely correlated
-0.63%
SNPX - BLRX
30%
Poorly correlated
+29.97%
AEON - BLRX
29%
Poorly correlated
+1.30%
More

KMSTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, KMSTF has been loosely correlated with IRON. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KMSTF jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMSTF
1D Price
Change %
KMSTF100%
N/A
IRON - KMSTF
54%
Loosely correlated
+0.40%
ZVRA - KMSTF
30%
Poorly correlated
-0.54%
ACUT - KMSTF
28%
Poorly correlated
N/A
SRZN - KMSTF
28%
Poorly correlated
-4.02%
BLRX - KMSTF
24%
Poorly correlated
-1.90%
More